NCT06078098 Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
| NCT ID | NCT06078098 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Milano Bicocca |
| Condition | Autoimmune Hepatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2023-03-29 |
| Primary Completion | 2034-03-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2023-03-29 with a primary completion date of 2034-03-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Autoimmune Hepatitis (AIH) is chronic fibroinflammatory disease of the liver characterized by chronic, relapsing liver inflammation, and a risk for progression to liver failure and need for liver transplantation. No AIH-specific registry does exist in Italy, so that the actual epidemiology of the disease in the country is unknown. This is an observational, retrospective and prospective, multicenter study evaluating incidence, prevalence and disease course of AIH in subjects \> 1 years old in Italy.
Eligibility Criteria
Inclusion Criteria: * All AIH patients living in Italy and aged at least 1 year can be included in the database. * Willing and able to give informed consent prior to any study specific procedure being * Diagnosis of AIH according to the most recent published guidelines (EASL) Exclusion Criteria: * Subject unwilling to participate at the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06078098 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, studying Autoimmune Hepatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06078098 currently recruiting?
Yes, NCT06078098 is actively recruiting participants. Contact the research team at pietro.invernizzi@unimib.it for enrollment information.
Where is the NCT06078098 trial being conducted?
This trial is being conducted at Monza, Italy.
Who is sponsoring the NCT06078098 clinical trial?
NCT06078098 is sponsored by University of Milano Bicocca. The trial plans to enroll 10,000 participants.